Valbiotis SA
ALVAL
Company Profile
Business description
Valbiotis SA is a research & development company. It is engaged in scientific innovation for preventing and combating metabolic diseases. Valbiotis has adopted an approach, aiming to revolutionize healthcare by developing a new class of Nutrition Health products designed to reduce the risk of major metabolic diseases, based on a multi-target approach by the use of plant-based ingredients.
Contact
12F rue Paul VATINE
Perigny
La Rochelle17180
FRAT: +33 546286258
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
55
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,244.80 | 11.80 | -0.13% |
CAC 40 | 8,060.13 | 85.28 | 1.07% |
DAX 40 | 24,597.13 | 211.35 | 0.87% |
Dow JONES (US) | 46,796.36 | 193.38 | 0.41% |
FTSE 100 | 9,548.87 | 65.29 | 0.69% |
HKSE | 26,829.46 | 128.31 | -0.48% |
NASDAQ | 22,978.77 | 190.40 | 0.84% |
Nikkei 225 | 47,734.99 | 215.89 | -0.45% |
NZX 50 Index | 13,568.48 | 37.19 | 0.27% |
S&P 500 | 6,752.09 | 37.50 | 0.56% |
S&P/ASX 200 | 8,947.60 | 10.80 | -0.12% |
SSE Composite Index | 3,882.78 | 20.25 | 0.52% |